Cancer stem cells and neuroblastoma: characteristics and therapeutic targeting options V Veschi, F Verona, CJ Thiele Frontiers in endocrinology 10, 782, 2019 | 43 | 2019 |
Cancer stem cells in thyroid tumors: from the origin to metastasis V Veschi, F Verona, M Lo Iacono, C D'Accardo, G Porcelli, A Turdo, ... Frontiers in Endocrinology 11, 566, 2020 | 32 | 2020 |
Messing up the cancer stem cell chemoresistance mechanisms supported by tumor microenvironment M Gaggianesi, S Di Franco, VD Pantina, G Porcelli, C D'Accardo, ... Frontiers in Oncology 11, 702642, 2021 | 27 | 2021 |
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 A Turdo, M Gaggianesi, S Di Franco, V Veschi, C D’Accardo, G Porcelli, ... Oncogene 41 (15), 2196-2209, 2022 | 15 | 2022 |
Metabolic escape routes of cancer stem cells and therapeutic opportunities A Turdo, G Porcelli, C D’Accardo, S Di Franco, F Verona, S Forte, ... Cancers 12 (6), 1436, 2020 | 14 | 2020 |
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells V Veschi, A Turdo, C Modica, F Verona, S Di Franco, M Gaggianesi, ... Nature Communications 14 (1), 1351, 2023 | 10 | 2023 |
Targeting epigenetic alterations in cancer stem cells P VD Frontiers in Molecular Medicine 2, 1011882, 2022 | 6 | 2022 |
Dual inhibition of myc transcription and PI3K activity effectively targets colorectal cancer stem cells M Gaggianesi, LR Mangiapane, C Modica, VD Pantina, G Porcelli, ... Cancers 14 (3), 673, 2022 | 4 | 2022 |
The role of driver mutations in the initiation and progression of thyroid cancer F VERONA, A TUTTOLOMONDO, G STASSI, V VESCHI Università degli Studi di Palermo, 2024 | | 2024 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas A Turdo, M Gaggianesi, C D’Accardo, G Porcelli, SD Bella, D Cricchio, ... Frontiers in Immunology 14, 1266265, 2023 | | 2023 |